Pharma Edge Centre (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -33.31%
- Profit Growth -12.44%
- Ebitda -4.71%
- Net Worth 22.73%
- Total Assets -35.29%
About Pharma Edge Centre (India)
Pharma Edge Centre (India) Private Limited (PECIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 September 2008 and has a history of 16 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vinay Shedbalkar and Rajaram Patil serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900TG2008PTC061020
-
Company No.
061020
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Sep 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pharma Edge Centre (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Shedbalkar
|
Director | 15-Sep-2008 | Current |
|
Rajaram Patil
|
Director | 15-Sep-2008 | Current |
Financial Performance of Pharma Edge Centre (India).
Pharma Edge Centre (India) Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 33.31% decrease. The company also saw a substantial fall in profitability, with a 12.44% decrease in profit. The company's net worth Soared by an impressive increase of 22.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Edge Centre (India)?
In 2017, Pharma Edge Centre (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Omacon Analytical Solutions LlpRajaram Patil is a mutual person
-
Om Analytical India Private Limited
Rajaram Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharma Edge Centre (India)?
Unlock and access historical data on people associated with Pharma Edge Centre (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Edge Centre (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Edge Centre (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
